Pankey Jessica A, Christofferson Scott, Barrick Ginger, Knettel Brandon A, Knettel Christine
UNC Rex Healthcare, Raleigh, NC, USA.
Duke University, Durham, NC, USA.
Hosp Pharm. 2022 Dec;57(6):759-766. doi: 10.1177/00185787221115664. Epub 2022 Jul 30.
This study aimed to evaluate the frequency at which postintubation sedation is administered following use of long-acting paralytic agents compared to short-acting paralytic agents during rapid sequence intubation performed in the emergency department. This retrospective, single-center study of intubated patients in the emergency department analyzed the difference in time to administration of additional sedation following use of a short-acting paralytic (succinylcholine) compared to use of a long-acting paralytic (rocuronium or vecuronium). A total of 387 patients were available for analysis. The primary outcome was additional sedation given within 15 minutes following administration of a paralytic agent. The secondary outcome sought to evaluate the incidence of hyperkalemia due to paralytic agents by comparing potassium level before and after paralytic administration. 46.9% of patients who received a short-acting paralytic agent received additional sedation within 15 minutes, compared to 40.9% of patients who received a long-acting paralytic agent. The Chi-square analysis comparing the short and long-acting paralytic groups showed no statistically significant difference (χ² [1, N = 387] = 1.24, = .266) in the frequency of additional sedation administered. Excluding patients who did not receive any additional sedation, the mean time from paralytic administration to additional sedation in all patients was 20.03 ± 18 minutes. No statistically significant difference was detected between groups regarding changes in potassium level. The use of long-acting paralytic agents was not associated with increased time to administration of sedation compared to shortacting paralytic agents. There is an opportunity to reduce the time to sedation administration for intubated patients receiving both short- and long-acting paralytic agents.
本研究旨在评估在急诊科进行快速顺序插管时,与使用短效麻痹剂相比,使用长效麻痹剂后给予插管后镇静的频率。这项针对急诊科插管患者的回顾性单中心研究分析了使用短效麻痹剂(琥珀酰胆碱)与使用长效麻痹剂(罗库溴铵或维库溴铵)后给予额外镇静的时间差异。共有387例患者可供分析。主要结局是在给予麻痹剂后15分钟内给予额外镇静。次要结局旨在通过比较麻痹剂给药前后的钾水平来评估麻痹剂导致高钾血症的发生率。接受短效麻痹剂的患者中有46.9%在15分钟内接受了额外镇静,而接受长效麻痹剂的患者中这一比例为40.9%。比较短效和长效麻痹剂组的卡方分析显示,额外镇静给药频率无统计学显著差异(χ²[1, N = 387] = 1.24,P = 0.266)。排除未接受任何额外镇静的患者后,所有患者从麻痹剂给药到额外镇静的平均时间为20.03±18分钟。两组之间在钾水平变化方面未检测到统计学显著差异。与短效麻痹剂相比,使用长效麻痹剂与给予镇静的时间增加无关。对于接受短效和长效麻痹剂的插管患者,有机会减少给予镇静的时间。